A Study Of A New Medicine (GW597599B) For The Treatment Of Major Depressive Disorder

Clinical trial NCT00048204 · COMPLETED

Trial details

NCT number: NCT00048204
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Depressive Disorder, Major

Start date: 2002-11-04
Primary completion: 2003-09-30
Enrollment: 372

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.